| FDA Panel Okays Chelsea Therapeutics' Neuro Drug Northera; Shares Up 70% - RTT News |
|
|
RTT News The FDA Cardiovascular and Renal Drugs Advisory Committee recommended that Northera can be approved to treat symptomatic neurogenic orthostatic hypotension, or NOH - a rare, chronic and often debilitating drop in blood pressure on standing up, ... Split FDA Panel Favors Droxidopa for Hypotension MedPage Today FDA Advisory Panel Recommends Approval of Chelsea's NORTHER(TM) (droxidopa |